Skip to main content
    E

    Enveric Biosciences Inc (ENVB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.44
    -0.08 (-4.95%)

    Market Cap: $6.78M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Enveric Biosciences Inc (ENVB) Earnings: Report Dates and Results

    Updated Nov 13, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Enveric Biosciences (ENVB) is expected to report earnings on Mar 25, 2027. In the quarter ended Sep 30, 2026, Enveric Biosciences reported EPS of -$0.57. It beat the EPS estimate in 6 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    64%(14/22)
    Avg Surprise
    -25.41%

    Next Report

    ENVB has an expected report date of Mar 25, 2027.

    Earnings History

    Of the 22 quarters below that had an estimate, ENVB beat 14 and missed 8. The widest gap in the table came in the quarter ended Dec 31, 2018, when EPS landed 700.00% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.57N/AN/AN/AN/AN/AN/AN/ANov 13, 2026N/A
    Jun 30, 2026-$0.76N/AN/AN/AN/AN/AN/AN/AAug 14, 2026N/A
    Mar 31, 2026-$1.08N/AN/AN/AN/AN/AN/AN/AMay 15, 2026N/A
    Dec 31, 2025-$3.81N/AN/AN/AN/AN/AN/AN/AMar 27, 2026N/A
    Sep 30, 2025-$10.81-$0.35N/AN/AN/AN/AN/AN/ANov 14, 2025N/A
    Jun 30, 2025-$11.65-$0.35N/AN/AN/AN/AN/A0 up, 0 downAug 14, 2025N/A
    Mar 31, 2025-$4.82-$4.80N/A-0.31%MissN/AN/AN/AMay 14, 2025N/A
    Dec 31, 2024-$2.03-$2.76N/A+26.45%BeatN/AN/A0 up, 0 downMar 31, 2025$340376
    Sep 30, 2024-$43.20-$93.60N/A+53.85%BeatN/AN/A0 up, 0 downNov 14, 2024N/A
    Jun 30, 2024-$45.00-$99.00N/A+54.55%BeatN/A10 up, 0 downAug 12, 2024N/A
    Mar 31, 2024-$109.80-$139.50-$169.18 - -$109.79+21.29%BeatN/A20 up, 0 downMay 14, 2024N/A
    Dec 31, 2023-$1.47-$1.54-$1.59 - -$1.50+4.55%BeatN/A20 up, 0 downMar 25, 2024$647092
    Sep 30, 2023-$287.12-$376.20-$404.96 - -$347.37+23.68%BeatN/A20 up, 0 downNov 13, 2023N/A
    Jun 30, 2023-$450.42-$117.00N/A-284.97%MissN/AN/AN/AAug 14, 2023N/A
    Mar 31, 2023-$4.24-$2.23N/A-89.91%MissN/AN/A0 up, 0 downMay 15, 2023N/A
    Dec 31, 2022-$344.11-$525.60N/A+34.53%BeatN/AN/A0 up, 0 downMar 31, 2023N/A
    Sep 30, 2022-$582.21-$720.00-$809.92 - -$629.94+19.14%BeatN/A20 up, 0 downNov 14, 2022N/A
    Jun 30, 2022-$818.08-$675.00N/A-21.20%MissN/AN/A0 up, 0 downAug 12, 2022N/A
    Mar 31, 2022-$990.00-$1,080.00-$1,439.86 - -$719.93+8.33%BeatN/A20 up, 0 downMay 13, 2022N/A
    Dec 31, 2021-$89.00-$8.00-$8.50 - -$7.50N/AN/AN/A20 up, 0 downMar 31, 2022N/A
    Sep 30, 2021-$1,080.00-$1,260.00N/A+14.29%BeatN/A2N/ANov 15, 2021N/A
    Jun 30, 2021-$1,800.00-$1,575.00-$1,799.82 - -$1,349.87-14.29%MissN/A2N/AAug 13, 2021N/A
    Mar 31, 2021-$0.04-$9.50N/A+99.58%BeatN/AN/AN/AApr 1, 2021N/A
    Sep 30, 2020-$0.04N/AN/AN/AN/AN/AN/AN/ANov 16, 2020$8.48M
    Jun 30, 2020-$0.48N/AN/AN/AN/AN/AN/AN/AAug 14, 2020$8.25M
    Mar 31, 2020-$0.04N/AN/AN/AN/AN/AN/AN/AMay 15, 2020$9.60M
    Sep 30, 2019-$0.03-$5.00N/A+99.50%BeatN/AN/AN/ANov 8, 2019$9.15M
    Jun 30, 2019-$0.75-$150.00N/A+99.50%BeatN/AN/AN/AAug 14, 2019$11.02M
    Mar 31, 2019-$1.00N/AN/AN/AN/AN/AN/AN/AMay 14, 2019$10.69M
    Dec 31, 2018-$1,600.00-$200.00N/A-700.00%MissN/AN/AN/AMar 26, 2019$10.28M
    Sep 30, 2018-$300.00-$250.00N/A-20.00%MissN/AN/AN/ANov 14, 2018$10.58M
    Jun 30, 2018-$300.00-$400.00N/A+25.00%BeatN/AN/AN/AAug 14, 2018$11.08M
    Mar 31, 2018-$2.25-$2.00N/A-12.50%MissN/AN/AN/AApr 2, 2018$11.06M
    Sep 30, 2017-$5.50N/AN/AN/AN/AN/AN/AN/ANov 13, 2017$12.53M
    Jun 30, 2017-$0.26N/AN/AN/AN/AN/AN/AN/AAug 14, 2017$12.27M
    Mar 31, 2017-$0.09N/AN/AN/AN/AN/AN/AN/AMay 12, 2017$12.34M
    Dec 31, 2016$9.37N/AN/AN/AN/AN/AN/AN/AMar 31, 2017$12.39M
    Sep 30, 2016-$12.59N/AN/AN/AN/AN/AN/AN/ANov 14, 2016$10.06M
    Jun 30, 2016-$9.42N/AN/AN/AN/A-100.2%N/AN/AAug 12, 2016$6.69M
    Mar 31, 2016-$87,941.09N/AN/AN/AN/AN/AN/AN/AMay 16, 2016$7.01M
    Last 40 quarters

    Estimates made before a stock split are shown on the same share basis as the reported EPS.

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$31.08, after -$200.03 the year before. It was -$210.15 for the year ended Dec 31, 2013, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$31.08N/A
    Dec 31, 2024-$200.03N/A
    Dec 31, 2023-$743.25N/A
    Dec 31, 2022-$2,734.40N/A
    Dec 31, 2021-$2,971.38N/A
    Dec 31, 2018-$2,208.10N/A
    Dec 31, 2016-$87,953.73N/A
    Dec 31, 2015-$148,756.33N/A
    Dec 31, 2014-$34,877.44N/A
    Dec 31, 2013-$210.15N/A

    Frequently Asked Questions About ENVB

    When is Enveric Biosciences's next earnings date?

    Enveric Biosciences's next earnings report is expected for Mar 25, 2027.

    How often does ENVB beat earnings estimates?

    Enveric Biosciences beat the EPS estimate in 6 of the 8 most recent quarters that had an estimate, with an average surprise of -12.62%.